IDEXX Laboratories, Inc.
IDXX
Κατάταξη σε μετοχές
#553
IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing,... IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.
Τιμή μετοχής
$557.81
Τελευταίος συγχρονισμός: 2026-10-19
Κεφαλαιοποίηση
$43.94B
Αλλαγή (1 ημέρα)
-0.46%
Αλλαγή (1 έτος)
-13.30%
Χώρα
US
Εμπόριο IDEXX Laboratories, Inc. (IDXX)
Κατηγορία
Healthcare
Λειτουργικό Περιθώριο για IDEXX Laboratories, Inc. (IDXX)
Λειτουργικό Περιθώριο στις October 2026 TTM: 32.03%
Σύμφωνα με τις τελευταίες οικονομικές αναφορές και την τιμή μετοχής της IDEXX Laboratories, Inc., το τρέχον Λειτουργικό Περιθώριο (TTM) είναι 32.03%. Στο τέλος του 2024, το Λειτουργικό Περιθώριο ήταν 28.95%.
Ιστορικό Λειτουργικού Περιθωρίου για την IDEXX Laboratories, Inc. από 2000 έως 2026
Λειτουργικό Περιθώριο στο τέλος κάθε έτους
| Έτος | Λειτουργικό Περιθώριο | Αλλαγή |
|---|---|---|
| 2026 (TTM) | 32.03% | 1.36% |
| 2025 | 31.60% | 9.15% |
| 2024 | 28.95% | -3.40% |
| 2023 | 29.97% | 12.29% |
| 2022 | 26.69% | -7.93% |
| 2021 | 28.99% | 12.98% |
| 2020 | 25.66% | 11.71% |
| 2019 | 22.97% | 3.47% |
| 2018 | 22.20% | 5.82% |
| 2017 | 20.98% | 6.34% |
| 2016 | 19.73% | 5.40% |
| 2015 | 18.72% | 6.85% |
| 2014 | 17.52% | -9.55% |
| 2013 | 19.37% | -4.58% |
| 2012 | 20.30% | 4.75% |
| 2011 | 19.38% | 4.87% |
| 2010 | 18.48% | 8.32% |
| 2009 | 17.06% | 1.31% |
| 2008 | 16.84% | 14.09% |
| 2007 | 14.76% | -14.73% |
| 2006 | 17.31% | -4.21% |
| 2005 | 18.07% | -8.13% |
| 2004 | 19.67% | 16.46% |
| 2003 | 16.89% | 5.89% |
| 2002 | 15.95% | 8.87% |
| 2001 | 14.65% | 1.10% |
| 2000 | 14.49% | 0.00% |
Λειτουργικό Περιθώριο για παρόμοιες εταιρείες ή ανταγωνιστές
| Εταιρεία | Λειτουργικό Περιθώριο | Διαφορά Λειτουργικού Περιθωρίου | Χώρα |
|---|---|---|---|
| 17.97% | -99.44% |
US
|
|
| 20.42% | -99.36% |
US
|
|
| -10.70% | -100.33% |
US
|
|
| 0.00% | - |
CN
|
|
| 22.23% | -99.31% |
US
|
Τι είναι το Λειτουργικό Περιθώριο μιας εταιρείας;
Το Λειτουργικό Περιθώριο είναι ένας βασικός δείκτης για την αξιολόγηση της κερδοφορίας μιας εταιρείας. Όσο υψηλότερο είναι το Operating Margin, τόσο το καλύτερο, καθώς δείχνει ότι η εταιρεία πωλεί τα προϊόντα ή τις υπηρεσίες της με σημαντικό περιθώριο κέρδους. Υπολογίζεται διαιρώντας τα κέρδη της εταιρείας με τα έσοδά της.